PATRIARCA, ANDREA
 Distribuzione geografica
Continente #
EU - Europa 1.644
NA - Nord America 1.353
AS - Asia 1.234
SA - Sud America 144
AF - Africa 43
OC - Oceania 9
Totale 4.427
Nazione #
US - Stati Uniti d'America 1.294
SG - Singapore 484
RU - Federazione Russa 476
IT - Italia 353
IE - Irlanda 260
CN - Cina 201
VN - Vietnam 169
HK - Hong Kong 147
DE - Germania 145
SE - Svezia 121
BR - Brasile 104
FR - Francia 76
BD - Bangladesh 54
IN - India 54
FI - Finlandia 50
GB - Regno Unito 43
CA - Canada 36
UA - Ucraina 29
KR - Corea 24
ID - Indonesia 19
MX - Messico 19
TR - Turchia 18
BJ - Benin 17
PL - Polonia 16
AR - Argentina 14
NL - Olanda 14
ZA - Sudafrica 12
CZ - Repubblica Ceca 11
LT - Lituania 11
ES - Italia 10
AU - Australia 9
IR - Iran 9
PK - Pakistan 9
JP - Giappone 8
AT - Austria 7
CL - Cile 6
CO - Colombia 5
EC - Ecuador 5
IQ - Iraq 5
SA - Arabia Saudita 5
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BE - Belgio 3
DZ - Algeria 3
ET - Etiopia 3
JO - Giordania 3
MA - Marocco 3
PH - Filippine 3
PY - Paraguay 3
RS - Serbia 3
TH - Thailandia 3
UZ - Uzbekistan 3
BG - Bulgaria 2
CR - Costa Rica 2
DK - Danimarca 2
EG - Egitto 2
KZ - Kazakistan 2
LV - Lettonia 2
MY - Malesia 2
PE - Perù 2
SY - Repubblica araba siriana 2
AL - Albania 1
AO - Angola 1
BO - Bolivia 1
CH - Svizzera 1
DM - Dominica 1
EE - Estonia 1
GE - Georgia 1
HU - Ungheria 1
KE - Kenya 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PT - Portogallo 1
RO - Romania 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
YE - Yemen 1
Totale 4.427
Città #
Dublin 253
San Jose 216
Hong Kong 147
Singapore 137
Ashburn 121
Piemonte 70
Chandler 66
Los Angeles 66
Beijing 59
Novara 57
Council Bluffs 53
Ho Chi Minh City 43
Moscow 42
Munich 42
New York 41
Helsinki 40
Lauterbourg 39
Hanoi 36
Jacksonville 34
Orem 29
Lawrence 25
Princeton 25
Boardman 24
Bremen 21
Seoul 21
Buffalo 20
Santa Clara 19
Chennai 18
Frankfurt am Main 18
Toronto 18
Columbus 17
Cotonou 17
São Paulo 17
San Mateo 16
Milan 15
Falkenstein 14
Genoa 13
Grafing 13
Haiphong 13
London 13
Wilmington 13
Atlanta 12
Dallas 12
Turin 12
Brooklyn 11
Guangzhou 11
Jakarta 11
Montreal 11
Phoenix 11
Warsaw 11
Mexico City 10
Nuremberg 10
Rome 10
St Louis 10
Strasbourg 10
Turku 10
Brno 9
Houston 9
Poplar 9
Dong Ket 8
Redondo Beach 8
Stockholm 8
Sydney 8
Amsterdam 7
Andover 7
Da Nang 7
Johannesburg 7
Assago 6
Shanghai 6
Tokyo 6
Ankara 5
Bexley 5
Bologna 5
Boston 5
Chicago 5
Mumbai 5
Naples 5
New Delhi 5
Vercelli 5
Dalian 4
Denver 4
Hefei 4
Islamabad 4
Istanbul 4
Santiago 4
Tianjin 4
Vienna 4
West Jordan 4
Addis Ababa 3
Baku 3
Barnet 3
Belgrade 3
Belo Horizonte 3
Berlin 3
Brussels 3
Charlotte 3
Leawood 3
Milwaukee 3
Mülheim 3
Norwalk 3
Totale 2.345
Nome #
Comparative Analysis of the Performance of Automated Digital Cell Morphology Analyzers for Leukocyte Differentiation in Hematologic Malignancies: Mindray MC‐80 Versus West Medical Vision Hema 234
A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study 233
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry 170
Time-Dependent COVID-19 Mortality in Patients with Cancer: An Updated Analysis of the OnCovid Registry 134
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia 133
Targeting p53 in chronic lymphocytic leukemia 132
Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients 130
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: The OnCovid Inflammatory Score 130
Genetic predisposition to myelodysplastic syndromes: A challenge for adult hematologists 129
Presenting features and early mortality from SARS-CoV-2 infection in cancer patients during the initial stage of the COVID-19 pandemic in Europe 122
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients 119
Multiregional sequencing and circulating tumour DNA analysis provide complementary approaches for comprehensive disease profiling of small lymphocytic lymphoma 119
Induction of robust humoral immunity against SARS-CoV-2 after vaccine administration in previously infected haematological cancer patients 116
An update on: molecular genetics of high-risk chronic lymphocytic leukemia 115
Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer 114
Precision medicine management of chronic lymphocytic leukemia 110
Atypical chronic myeloid leukemia: Where are we now? 110
Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms 110
Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries 109
Lymphocyte doubling time in chronic lymphocytic leukemia modern era: a real-life study in 848 unselected patients 107
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry 104
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study 103
Precision Medicine in Systemic Mastocytosis 103
Eltrombopag second-line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off-treatment: results of a phase II, multicentre, prospective study 102
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL 101
A step ahead toward precision medicine for chronic lymphocytic leukemia 100
An acquired factor V inhibitor induced uncontrolled bleeding in a postsurgery patient 100
High reproducibility of spleen stiffness measurement by vibration-controlled transient elastography with a spleen-dedicated module 96
A phase 3 study of pelebresib plus ruxolitinib for JAK inhibitor-naive patients with myelofibrosis 95
Venetoclax with Hypomethylating Agents in Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis of Survival Data from Real-World Studies 92
High BECN1 Expression Negatively Correlates with BCL2 Expression and Predicts Better Prognosis in Diffuse Large B-Cell Lymphoma: Role of Autophagy 92
A Rare Case of Life-Threatening Jaundice Caused by Epstein-Barr Virus Infection and Secondary Cold Agglutinin Syndrome Successfully Treated with Rituximab 90
The Biology of Chronic Lymphocytic Leukemia: Diagnostic and Prognostic Implications 90
Ponatinib for the treatment of Ph-like acute lymphoblastic leukemia 88
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study 88
Cerebrospinal fluid xanthochromia after pegasparaginase hepatotoxicity in B-cell acute lymphoblastic leukemia 83
Prescription patterns of venetoclax in acute myeloid leukemia 79
Intravascular lymphoma: from vessels to genes 55
Investigational drugs for the treatment of diffuse large B-cell lymphoma 54
Innovative Use of Fostamatinib in Managing Refractory Immune Thrombocytopenia in an HIV ‐Positive Patient: A Case Report 44
Real‐world efficacy and safety of fostamatinib in ITP patients: Italian multicentre experience. GIMEMA ITP1122 study 32
Diagnostic Challenges in a Young Man with a Suspected Mast Cell Disorder, Dysplastic Bone Marrow Morphology, and a ZRSR2 Mutation 30
Liquid biopsy in lymphomas: a potential tool for refining diagnosis and disease monitoring 6
Assessing prognosis of chronic lymphocytic leukemia using biomarkers and genetics 4
Totale 4.507
Categoria #
all - tutte 21.626
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.626


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 0 0 0 0 0 0 0 11
2021/2022274 7 4 21 34 18 10 23 13 13 36 50 45
2022/2023543 46 22 47 4 35 47 25 20 250 3 25 19
2023/2024269 27 23 23 7 38 9 36 6 4 5 37 54
2024/2025824 21 19 43 10 28 30 47 138 124 51 113 200
2025/20262.436 116 76 121 273 263 164 371 409 187 214 131 111
Totale 4.507